InMed Pharmaceuticals INM
NASDAQ INM
$1.60 +0.01 (+0.62%)
At close: Aug 20, 2026 · 12:32 PM UTC

InMed Pharmaceuticals (INM) Prepaid Assets (2020 - 2026)

InMed Pharmaceuticals (INM) posted quarterly Prepaid Assets of $617211.0 for Q1 2026, up 21.53% year-over-year from $507872.0 in Q1 2025, and down 6.52% quarter-over-quarter from $660280.0 in Q4 2025.

InMed Pharmaceuticals (INM) Prepaid Assets (2020 - 2026) Analysis & Trends

InMed Pharmaceuticals' Prepaid Assets history runs 7 years deep, the most recent figure standing at $617211.0 for Q1 2026.

  • In Q1 2026, Prepaid Assets rose 21.53% year-over-year to $617211.0; the TTM figure through Mar 2026 stood at $617211.0 (up 21.53% YoY), while the FY2025 annual figure was $319547.0, down 33.11% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $617211.0, down from $660280.0 in the prior quarter.
  • The five-year high for Prepaid Assets was $1.3 million in Q1 2022, with the low at $148882.0 in Q3 2024.
  • The 5-year median for Prepaid Assets is $617211.0 (2026), against an average of $611738.6.
  • The sharpest annual moves came in 2022 and 2025: Prepaid Assets jumped 488.51% in 2022, then plunged 50.14% in 2025.
  • InMed Pharmaceuticals' Prepaid Assets stood at $826931.0 in 2022, then jumped by 34.59% to $1.1 million in 2023, then plunged by 42.14% to $643986.0 in 2024, then rose by 2.53% to $660280.0 in 2025, then slipped by 6.52% to $617211.0 in 2026.
  • Business Quant data shows INM's Prepaid Assets at $617211.0 in Q1 2026, $660280.0 in Q4 2025, and $191755.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn -
10 InMed Pharmaceuticals 6.48 Mn 1.24 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 617,211.00
Dec 31, 2025 660,280.00
Sep 30, 2025 191,755.00
Jun 30, 2025 319,547.00
Mar 31, 2025 507,872.00
Dec 31, 2024 643,986.00
Sep 30, 2024 148,882.00
Jun 30, 2024 477,749.00
Mar 31, 2024 1.02 Mn
Dec 31, 2023 1.11 Mn
Sep 30, 2023 215,015.00
Jun 30, 2023 498,033.00
Mar 31, 2023 695,203.00
Dec 31, 2022 826,931.00
Sep 30, 2022 356,665.00
Jun 30, 2022 797,225.00
Mar 31, 2022 1.31 Mn
Dec 31, 2021 140,512.00
Sep 30, 2021 322,352.00
Jun 30, 2021 956,762.00